Medpace Holdings Inc MEDP:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/01/24 EDT
397.86quote price arrow up+9.51 (+2.45%)
Volume
277,796
52 week range
197.39 - 421.00
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close397.86
  • 52 Week High421.00
  • 52 Week High Date04/24/24
  • 52 Week Low197.39
  • 52 Week Low Date05/24/23

Key Stats

  • Market Cap12.327B
  • Shares Out30.98M
  • 10 Day Average Volume0.32M
  • Dividend-
  • Dividend Yield-
  • Beta1.40
  • YTD % Change29.79

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close397.86
  • 52 Week High421.00
  • 52 Week High Date04/24/24
  • 52 Week Low197.39
  • 52 Week Low Date05/24/23
  • Market Cap12.327B
  • Shares Out30.98M
  • 10 Day Average Volume0.32M
  • Dividend-
  • Dividend Yield-
  • Beta1.40
  • YTD % Change29.79

RATIOS/PROFITABILITY

  • EPS (TTM)9.81
  • P/E (TTM)40.54
  • Fwd P/E (NTM)37.91
  • EBITDA (TTM)382.052M
  • ROE (TTM)61.31%
  • Revenue (TTM)1.963B
  • Gross Margin (TTM)27.99%
  • Net Margin (TTM)15.92%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date07/22/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Medpace Holdings Inc

Profile

MORE
Medpace Holdings, Inc. is a global provider of clinical research-based drug and medical device development services. The Company is focused on providing scientifically driven outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. Its drug development services focus on full-service Phase...
August Troendle M.D.
Chairman of the Board, Chief Executive Officer
Jesse Geiger CPA
President
Kevin Brady
Chief Financial Officer, Treasurer
Susan Burwig
Executive Vice President - Operations
Stephen Ewald J.D.
General Counsel, Corporate Secretary
Address
5375 Medpace Way
Cincinnati, OH
45227-1543
United States

Top Peers

SYMBOLLASTCHG%CHG
NBIX
Neurocrine Biosciences Inc
143.03+5.49+3.99%
SRPT
Sarepta Therapeutics Inc
130.90+4.24+3.35%
EXAS
Exact Sciences Corp
60.01+0.66+1.11%
NTRA
Natera Inc
94.15+1.27+1.37%
EXEL
Exelixis Inc
21.93-1.54-6.54%